Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupNeuro-OncologyradiotherapyDiseaseGlioblastomaSubgroupmethylated MGMT PromoterICD10C71.-MeSHGlioblastomaSequenceTMZL75/Radiation, Glioblastoma, C1 (PID546) -|- PGIFNA2B0.5/TMZL150, C2 (PID2473) -|- PGIFNA2B0.5/TMZL200, C3+ (PID2474)TMZL75/Radiation, Glioblastoma, C1 (PID546) -|- TMZL150, C2(PID547) -|- TMZL200 C3+ (PID548)TMZL75/Radiation, Glioblastoma, C1, var. 1 (PID3034) -|- C2 (PID3035) -|- C3-12 (PID3036)Antineoplastic therapySubstanceInterferon alpha-2b pegylatedLomustineTemozolomideSubstanceInterferon alpha-2b pegylatedLomustineTemozolomideSubstanceInterferon alpha-2b pegylatedLomustineTemozolomideSubstanceInterferon alpha-2b pegylatedLomustineTemozolomideAnzahl Substanzen12 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneGranisetronSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneGranisetronSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneGranisetronSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneGranisetronAnzahl Substanzen34Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineRelapse therapyTherapy phaseTherapy intentionpalliativeRisksAnemia Hb below 8g/dlConstipationEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)FatigueHeadacheHepatotoxicityIncrease AminotransferasesInfectionsLeukopeniaNeutropeniaPyrexiaSeizuresThrombocytopenia below 50 000/µlThromboembolic Event only studiesPublicationAuthorGuo CHerrlinger UStupp R / Guo CDiseaseGlioblastom, ECOG 0-2neu diagnostiziertes Glioblastom, Karnofsky > 70%Neudiagnostiziertes high grade Gliom, Erstlinie, Karnofsky größer 60%OriginDepartment of Neurosurgery and Neurooncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology, South ChinaDepartment of Neurosurgery andNeurooncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology, South ChinaEORTC, NCICNeurooncology Working Group of the German Cancer Society, CeTeG/NOA–09Protocols in Revision 7 protocols foundLomustine 100 / Temozolomide 100 / Radiation, Glioblastoma (PID488 V1.2)Peginterferon alpha-2b 0.5 / Temozolomide 150, Glioblastoma, cycle 2 (PID2473 V2.0)Peginterferon alpha-2b 0.5 / Temozolomide 200, Glioblastoma, cycle 3+ (PID2474 V2.0)Temozolomide 150, Glioblastoma, cycle 2, variant 1 (PID3035 V1.0)Temozolomide 200, Glioblastoma, cycle 3-12, variant 1 (PID3036 V1.0)Temozolomide 75 / Radiation, Glioblastoma, Cycle 1 (PID546 V1.2)Temozolomide 75 / Radiation, Glioblastoma, Cycle 1, Variant 1 (PID3034 V1.0)
